Published in Am J Epidemiol on March 01, 2003
Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci (2007) 2.12
Exposure-measurement error is frequently ignored when interpreting epidemiologic study results. Eur J Epidemiol (2006) 1.93
Neighborhood social cohesion and disorder in relation to walking in community-dwelling older adults: a multilevel analysis. J Aging Health (2009) 1.54
Neighborhood characteristics and disability in older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.32
Breast cancer screening and incidence in communities with a high proportion of uninsured. Am J Prev Med (2007) 1.11
Do positive or negative experiences of social support relate to current and future health? Results from the Doetinchem Cohort Study. BMC Public Health (2012) 1.01
Social participation and depression in old age: a fixed-effects analysis in 10 European countries. Am J Epidemiol (2015) 0.76
A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol (2005) 5.17
The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol (2011) 4.54
Breast cancer treatment of older women in integrated health care settings. J Clin Oncol (2006) 3.46
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42
Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology (2003) 3.30
Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat (2006) 2.55
Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg (2007) 2.43
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol (2009) 2.33
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst (2011) 2.27
Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res (2009) 2.23
Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23
Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study. Am J Epidemiol (2011) 2.12
Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer (2007) 1.94
Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology (2006) 1.87
Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol (2003) 1.85
Acute stress reaction and completed suicide. Int J Epidemiol (2010) 1.82
The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol (2010) 1.79
Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol (2002) 1.75
Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol (2010) 1.66
Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med (2007) 1.65
What's wrong with the National Ambient Air Quality Standard (NAAQS) for fine particulate matter (PM(2.5))? Regul Toxicol Pharmacol (2002) 1.59
Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev (2010) 1.55
Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer (2005) 1.50
Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer (2010) 1.46
Immortal person-time in studies of cancer outcomes. J Clin Oncol (2009) 1.40
Posttraumatic stress disorder and cancer risk: a nationwide cohort study. Eur J Epidemiol (2015) 1.39
If you want to know the end, look at the beginning. Epidemiology (2015) 1.39
Validity of birth certificate-derived maternal weight data. Paediatr Perinat Epidemiol (2014) 1.39
Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study. BMC Med Res Methodol (2007) 1.36
Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology (2008) 1.28
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol (2013) 1.26
Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study. Cancer (2009) 1.25
Validation of spontaneous abortion diagnoses in the Danish National Registry of Patients. Clin Epidemiol (2010) 1.16
Posttraumatic stress disorder and completed suicide. Am J Epidemiol (2010) 1.14
Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging. J Biol Chem (2006) 1.13
Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open (2013) 1.13
Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat (2006) 1.12
Validity of self-reported rheumatoid arthritis in a large cohort: results from the Black Women's Health Study. Arthritis Care Res (Hoboken) (2010) 1.07
Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res (2008) 1.07
The impact of National Death Index linkages on population-based cancer survival rates in the United States. Cancer Epidemiol (2012) 1.07
Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors. Med Care (2009) 1.07
No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications. Cancer Epidemiol Biomarkers Prev (2009) 1.06
Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue. Clin Epidemiol (2010) 1.06
Evidence and practice regarding the role for CYP2D6 inhibition in decisions about tamoxifen therapy. J Clin Oncol (2010) 1.06
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst (2012) 1.04
Breast cancer survival of American Indian/Alaska Native women, 1973-1996. Soz Praventivmed (2005) 1.03
Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis. Am J Physiol Endocrinol Metab (2007) 1.01
Variability in cancer death certificate accuracy by characteristics of death certifiers. Am J Forensic Med Pathol (2012) 1.00
Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study. Inflamm Bowel Dis (2008) 0.99
A null association between smoking during pregnancy and breast cancer using Massachusetts registry data (United States). Cancer Causes Control (2003) 0.98
Determinants and patterns of utilization of primary percutaneous coronary intervention across 12 European countries: 2003-2008. Int J Cardiol (2013) 0.97
Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. Eur J Cancer (2011) 0.97
Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis--a Danish nationwide matched cohort study. PLoS One (2013) 0.94
Breast cancer recurrence in older women five to ten years after diagnosis. Cancer Epidemiol Biomarkers Prev (2009) 0.94
Severe stress and adjustment disorder diagnoses in the population of Denmark. J Trauma Stress (2014) 0.94
The relationship among physicians' specialty, perceptions of the risks and benefits of adjuvant tamoxifen therapy, and its recommendation in older patients with breast cancer. Med Care (2004) 0.94
Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study. J Clin Oncol (2013) 0.94
Correspondence between general practitioner-reported medication use and timing of prescription dispensation. Clin Epidemiol (2012) 0.93
Correcting for exposure misclassification using survival analysis with a time-varying exposure. Ann Epidemiol (2012) 0.92
Delayed radiotherapy for breast cancer patients in integrated delivery systems. Am J Manag Care (2009) 0.92
Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes. Expert Rev Clin Pharmacol (2011) 0.91
Challenges associated with longitudinal survivorship research: attrition and a novel approach of reenrollment in a 6-year follow-up study of older breast cancer survivors. J Cancer Surviv (2008) 0.90
The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement. BMJ Qual Saf (2014) 0.90
Modification of tamoxifen response: what have we learned? J Clin Oncol (2008) 0.89
Risk of decline in upper-body function and symptoms among older breast cancer patients. J Gen Intern Med (2006) 0.89
The association between adjustment disorder diagnosed at psychiatric treatment facilities and completed suicide. Clin Epidemiol (2010) 0.89
Specifying exposure classification parameters for sensitivity analysis: family breast cancer history. Clin Epidemiol (2009) 0.89
Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation (2011) 0.89
Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study. Inflamm Bowel Dis (2013) 0.89
Trends in breast-conserving surgery in Denmark, 1982-2002. Eur J Epidemiol (2007) 0.88
Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control (2009) 0.87
Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ (2013) 0.87
Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study. Breast Cancer Res (2012) 0.86
Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality. Future Oncol (2010) 0.86
Persistent geographical disparities in the use of primary percutaneous coronary intervention in 120 European regions: exploring the variation. EuroIntervention (2013) 0.86
Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy. Future Oncol (2014) 0.85
Obesity as a risk factor for severe influenza-like illness. Influenza Other Respir Viruses (2013) 0.85
Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer. Breast J (2007) 0.85
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study. Breast Cancer Res (2010) 0.85
Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer. Breast Cancer Res Treat (2013) 0.85
Long-term statin use and the risk of gallstone disease: A population-based case-control study. Am J Epidemiol (2010) 0.84
Association between CYP2D6 polymorphisms and breast cancer outcomes. JAMA (2010) 0.84
Trauma, comorbidity, and mortality following diagnoses of severe stress and adjustment disorders: a nationwide cohort study. Am J Epidemiol (2015) 0.84
Predictors and outcomes of surgeons' referral of older breast cancer patients to medical oncologists. Cancer (2005) 0.84
The primary care pediatrician's influence on medical student's performance of smoking assessments and counseling. Prev Med (2004) 0.84
Mortality in cancer patients with a history of cutaneous squamous cell carcinoma--a nationwide population-based cohort study. BMC Cancer (2012) 0.83
Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Cancer (2002) 0.83
Mobile phone use and risk of uveal melanoma: results of the risk factors for uveal melanoma case-control study. J Natl Cancer Inst (2009) 0.83
Glyphosate results revisited. Environ Health Perspect (2005) 0.83
NO excess risk of breast cancer among female users of systemic glucocorticoids. Cancer Epidemiol Biomarkers Prev (2005) 0.82
Statin use and risk of amyotrophic lateral sclerosis and other motor neuron disorders. Circ Cardiovasc Qual Outcomes (2010) 0.82
Null association between pregnancy termination and breast cancer in a registry-based study of parous women. Int J Cancer (2004) 0.82
Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat (2014) 0.82
Estrogen-related and other disease diagnoses preceding Parkinson's disease. Clin Epidemiol (2010) 0.81
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2011) 0.81
Tamoxifen treatment in Danish breast cancer patients and 5-year risk of arterial atherosclerotic events: a null association. Cancer Epidemiol Biomarkers Prev (2008) 0.81
Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study. Breast Cancer Res (2010) 0.81